Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

5 Items

per page
  1. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  2. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  3. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  4. FT-207 (NSC 148958)
    B1474 FT-207 (NSC 148958)
    Summary: DNA/RNA synthesis inhibitor
      ≥100 mg/mL
  5. YC 1
    B7641 YC 1
    Target: Guanylyl Cyclases
    Summary: soluble guanylyl cyclase (sGC) activator
      ≥30.4 mg/mL

5 Items

per page
Relate Categories
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
  2. Related Disease Hepatocellular Carcinoma Remove This Item
Clear All